Journal
IMMUNOTHERAPY
Volume 7, Issue 5, Pages 473-476Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/IMT.15.21
Keywords
adoptive T-cell therapy; chimeric antigen receptor; gene engineering; immunotherapy; ovarian cancer; TCR; TILs
Categories
Funding
- NATIONAL CANCER INSTITUTE [P50CA083638, R01CA168900] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA168900, R01-CA168900, P50 CA083638] Funding Source: Medline